Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 2
2019 2
2020 2
2021 7
2022 6
2023 9
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of tofacitinib in rheumatoid arthritis-associated interstitial lung disease: TReasure real-life data.
Kalyoncu U, Bilgin E, Erden A, Satış H, Tufan A, Tekgöz E, Ateş A, Coşkun BN, Yağız B, Küçükşahin O, Yazısız V, Kimyon G, Bes C, Başıbüyük CS, Alkan S, Cesur TY, Ertenli İ, Kiraz S. Kalyoncu U, et al. Among authors: yagiz b. Clin Exp Rheumatol. 2022 Nov;40(11):2071-2077. doi: 10.55563/clinexprheumatol/9h6dtb. Epub 2022 Jan 25. Clin Exp Rheumatol. 2022. PMID: 35084323 Free article.
What predicts the recurrence in ıdiopathic granulomatous mastitis?
Lermi N, Ekin A, Ocak T, Bozkurt ZY, Ötegeçeli MA, Yağız B, Coşkun BN, Pehlivan Y, Dalkılıç E. Lermi N, et al. Among authors: yagiz b. Clin Rheumatol. 2023 Sep;42(9):2491-2500. doi: 10.1007/s10067-023-06651-3. Epub 2023 Jun 10. Clin Rheumatol. 2023. PMID: 37301771
Methotrexate intoxication: Beyond the adverse events.
Dalkilic E, Coskun BN, Yağız B, Tufan AN, Ermurat S, Pehlivan Y. Dalkilic E, et al. Among authors: yagiz b. Int J Rheum Dis. 2018 Aug;21(8):1557-1562. doi: 10.1111/1756-185X.13339. Int J Rheum Dis. 2018. PMID: 30146743
The predictors of paradoxical reactions, especially psoriasis, to biologic therapy-findings from the TReasure database: a 5-year follow-up study.
Yagiz B, Lermi N, Coskun BN, Dalkilic E, Kiraz S, Erden A, Ertenli I, Duran E, Bilgin E, Yılmaz R, Ateş A, Tufan A, Küçük H, Mercan R, Cinaklı H, Akar S, Yaşar Bilge NŞ, Kaşifoglu T, Türk SM, Gonullu EO, Bes C, Alpay Kanitez N, Emmungil H, Kalyoncu U, Pehlivan Y. Yagiz B, et al. Rheumatology (Oxford). 2023 Dec 1;62(12):3962-3967. doi: 10.1093/rheumatology/kead318. Rheumatology (Oxford). 2023. PMID: 37354493
Epidemiological characteristics of hepatitis B and C in patients with inflammatory arthritis: Implications from treasure database.
Ersözlü ED, Ekici M, Coşkun BN, Badak SÖ, Bilgin E, Kalyoncu U, Yağız B, Pehlivan Y, Küçükşahin O, Erden A, Solmaz D, Atagündüz P, Kimyon G, Beş C, Çolak S, Mercan R, Kaşifoğlu T, Emmungil H, Alpay Kanıtez N, Ateş A, Koca SS, Kiraz S, Ertenli İ. Ersözlü ED, et al. Among authors: yagiz b. Arch Rheumatol. 2022 Dec 2;38(3):347-357. doi: 10.46497/ArchRheumatol.2023.9504. eCollection 2023 Sep. Arch Rheumatol. 2022. PMID: 38046251 Free PMC article.
Rheumatology patients' attitude regarding Ramadan and fasting.
Pehlivan S, Pehlivan Y, Yağız B, Coşkun BN, Ermurat S, Dalkılıç E. Pehlivan S, et al. Among authors: yagiz b. Int J Rheum Dis. 2020 Aug;23(8):1082-1087. doi: 10.1111/1756-185X.13892. Epub 2020 Jun 30. Int J Rheum Dis. 2020. PMID: 32602648
Uveitis-related Factors in Patients With Spondyloarthritis: TReasure Real-Life Results.
Yaşar Bilge NŞ, Kalyoncu U, Atagündüz P, Dalkılıç E, Pehlivan Y, Küçükşahin O, Bes C, Akar S, Cinar M, Emmungil H, Ersözlü D, Ateş A, Mercan R, Kimyon G, Koca SS, Gonullu E, Yazisiz V, Tekgöz E, Alpay-Kanitez N, Erden A, Kiraz S, Coskun BN, Yağız B, İlgen U, Karadağ Ö, Kilic L, Ertenli İ, Kasifoglu T. Yaşar Bilge NŞ, et al. Among authors: yagiz b. Am J Ophthalmol. 2021 Aug;228:58-64. doi: 10.1016/j.ajo.2021.03.026. Epub 2021 Apr 4. Am J Ophthalmol. 2021. PMID: 33826929
Tocilizumab as a first line biologic agent in rheumatoid arthritis patients with inadequate response to disease-modifying anti-rheumatic drugs: real life experience from the TReasure Registry.
Karadag O, Farisogullari B, Yagiz B, Erden A, Ademoglu Z, Kimyon G, Bilge NS, Icacan OC, Kilic L, Coskun BN, Ersozlu ED, Kucuksahin O, Mercan R, Koca SS, Gonullu E, Cinar M, Akar S, Emmungil H, Kasifoglu T, Bes C, Omma A, Pehlivan Y, Kiraz S, Ertenli I, Dalkilic E, Kalyoncu U. Karadag O, et al. Among authors: yagiz b. Clin Exp Rheumatol. 2024 Jan;42(1):130-137. doi: 10.55563/clinexprheumatol/2h6ma1. Epub 2023 Aug 29. Clin Exp Rheumatol. 2024. PMID: 37650346 Free article.
28 results